(Q34430671)

2 August 2017

1 reference

title

Anti-inflammatory effects of macrolide antibiotics. (English)

1 reference

2 August 2017

0 references

0 references

Culić O

1

1 reference

2 August 2017

Eraković V

series ordinal

2

1 reference

2 August 2017

Parnham MJ

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

European Journal of Pharmacology

2 August 2017

1 reference

2 August 2017

429

1 reference

2 August 2017

1-3

1 reference

2 August 2017

209-229

1 reference

Effects of dirithromycin and erythromycylamine on human neutrophil degranulation

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Comparison of various macrolides on stimulation of human neutrophil degranulation in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected role

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin shortens neutrophil survival by accelerating apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Leukokinetic studies. III. The distribution of granulocytes in the blood of normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Function of human alveolar macrophages after a 3-day course of azithromycin in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Macrolides, asthma, inflammation, and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

NF-kappa B: ten years after

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Differential modulation of cytokine production by macrolides: interleukin-6 production is increased by spiramycin and erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Stimulation with cytokines enhances penetration of azithromycin into human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effects of rokitamycin on phagocytosis and release of oxidant radicals of human polymorphonuclear leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Directed neutrophil migration to IL-8 is increased in cystic fibrosis: a study of the effect of erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Comparative studies on the effects of erythromycin A and azithromycin upon extracellular release of lysosomal enzymes in inflammatory processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Regulation of granulocyte apoptosis and implications for anti-inflammatory therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Tilmicosin induces apoptosis in bovine peripheral neutrophils in the presence or in the absence of Pasteurella haemolytica and promotes neutrophil phagocytosis by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

The role of nuclear factor-kappa B in pulmonary diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effects of azithromycin on ozone-induced airway neutrophilia and cytokine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

FK506, an immunosuppressant targeting calcineurin function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

TNFα-INDUCED SUPPRESSION OF PMN APOPTOSIS IS MEDIATED THROUGH INTERLEUKIN-8 PRODUCTION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Azithromycin: indications for the future?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

[Evaluation of the effect of erythromycin on otitis media with effusion in experimental rat models]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

The effect of antimicrobial agents on leukocyte chemotaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

The effects of ketolides on bioactive phospholipid-induced injury to human respiratory epithelium in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Antibiotics and neutrophil function--potential immunomodulating activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Cell acidification in apoptosis: granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H(+)-ATPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effect of a 17-member azalide on tumor cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Antitumor effect of erythromycin in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Interactions of dirithromycin with human polymorphonuclear leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Granulocyte apoptosis and its role in the resolution and control of lung inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Role of inducible nitric oxide synthase in the regulation of leucocyte recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Reversal of drug resistance by erythromycin: erythromycin increases the accumulation of actinomycin D and doxorubicin in multidrug-resistant cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Neutrophil chemotactic activity in cryptogenic organizing pneumonia and the response to erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Expression of nuclear factor-kappaB in Helicobacter pylori-infected gastric mucosa detected with southwestern histochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Description and status of the azithromycin and coronary events study (ACES).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Long-term azithromycin may improve lung function in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Rapamycin inhibits didemnin B-induced apoptosis in human HL-60 cells: evidence for the possible involvement of FK506-binding protein 25

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

The macrolide antibacterial roxithromycin reduces bronchial hyperresponsiveness and superoxide anion production by polymorphonuclear leukocytes in patients with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Polyketide synthesis: prospects for hybrid antibiotics

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

7 January 2021

Novel macrolides through genetic engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Vacuolar H(+)-ATPases. Targets for drug discovery?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effect of clarithromycin and azithromycin on production of cytokines by human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Enhanced interleukin production after long-term administration of erythromycin stearate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Alterations of host response by a long-term treatment of roxithromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

On the search for extant life on Mars

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Apoptosis, oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effect of roxithromycin on peripheral neutrophil adhesion molecules in patients with chronic lower respiratory tract disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Anti-inflammatory activity of macrolides: a new therapeutic potential?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Immunological effects of macrolides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Immunomodulation by macrolide antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Azithromycin impact on neutrophil oxidative metabolism depends on exposure time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Time and concentration dependent influence of dirithromycin on neutrophils oxidative burst

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin inhibits beta2-integrins (CD11b/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Uptake, accumulation, and egress of erythromycin by tissue culture cells of human origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Chemistry and mode of action of macrolides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Phagocyte uptake and transport of azithromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Chlamydia pneumoniae activates nuclear factor kappaB and activator protein 1 in human vascular smooth muscle and induces cellular proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Release of nitric oxide and expression of constitutive nitric oxide synthase of human endothelial cells: enhancement by a 14-membered ring macrolide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Interactions of Macrolide Antibiotics (Erythromycin A, Roxithromycin, Erythromycylamine [Dirithromycin], and Azithromycin) with Phospholipids: Computer-Aided Conformational Analysis and Studies on Acellular and Cell Culture Models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

A macrolide antibiotic, roxithromycin, inhibits the growth of human myeloid leukemia HL60 cells by producing multinucleate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Reduced nasal nitric oxide in diffuse panbronchiolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Nitric oxide as a secretory product of mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Role of nitric oxide synthesis in macrophage antimicrobial activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Nitric oxide synthases: Roles, tolls, and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Reduced intracellular activity of antibiotics against Listeria monocytogenes in multidrug resistant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Specific inhibitors of vacuolar type H(+)-ATPases induce apoptotic cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Postantibiotic leukocyte enhancement of meropenem against gram-positive and gram-negative strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Macrolides reduce the expression of surface Mac-1 molecule on neutrophil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Macrolides with gastrointestinal motor stimulating activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effects of roxithromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Factors affecting the intracellular accumulation and activity of azithromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Azithromycin uptake by tissue cultured epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Macrolides and immunity: effects of erythromycin and spiramycin on human mononuclear cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Differential modulatory effects of clarithromycin on the production of cytokines by a tumor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Macrophage recognition of senescent neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

In vivo uptake of azithromycin in human coronary plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome--a randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

The mechanism of action of cyclosporin A and FK506

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin treatment in diffuse panbronchiolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effect of macrolide antibiotics on neutrophil function in human peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Suppressive activity of a macrolide antibiotic, roxithromycin, on pro-inflammatory cytokine production in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Inhibitory effect of erythromycin on interleukin-8 secretion from exudative cells in the nasal discharge of patients with chronic sinusitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effect of erythromycin on ciliary motility in rabbit airway epithelium in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Macrolide antibiotics protect against endotoxin-induced vascular leakage and neutrophil accumulation in rat trachea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effects of roxithromycin and erythromycin on interleukin 8-induced neutrophil recruitment and goblet cell secretion in guinea pig tracheas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Chemokines and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Clarithromycin suppresses proliferation of rat nasal epithelium exposed to endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

In vivo administration of azithromycin affects lymphocyte activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

In vitro and ex vivo effects of recent and new macrolide antibiotics on chemotaxis of human polymorphonuclear leukocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Combinatorial biosynthesis of 'unnatural' natural products: the polyketide example

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Anti-inflammatory action of erythromycin. Its inhibitory effect on neutrophil NADPH oxidase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

The anti-inflammatory effects of macrolides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

NF-κB Activation Is a Critical Regulator of Human Granulocyte Apoptosisin Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Bacterial infection induces nitric oxide synthase in human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Comparison of macrolide antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Neutrophils: molecules, functions and pathophysiological aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Highlights of semi-synthetic developments from erythromycin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Effect of macrolide antibiotics on macrophage functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Inhibition of tumor angiogenesis by roxithromycin, a 14-membered ring macrolide antibiotic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Review of macrolides and ketolides: focus on respiratory tract infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

7 January 2021

The new ketolide HMR3647 accumulates in the azurophil granules of human polymorphonuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

7 January 2021

Modulatory effect of antibiotics on cytokine production by human monocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

7 January 2021

Therapeutic effect of clarithromycin on a transplanted tumor in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

7 January 2021

Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901321-8

7 January 2021

10.1016/S0014-2999(01)01321-8

Identifiers

DOI

1 reference

2 August 2017

1 reference